Načítá se...
Highly variable pharmacokinetics of dexmedetomidine during intensive care: a case report
INTRODUCTION: Dexmedetomidine is a selective and potent alpha2-adrenoceptor agonist licensed for use in the sedation of patients initially ventilated in intensive care units at a maximum dose rate of 0.7 μg/kg/h administered for up to 24 hours. Higher dose rates and longer infusion periods are somet...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2848065/ https://ncbi.nlm.nih.gov/pubmed/20184754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-4-73 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|